Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
When facing an endometrial cancer diagnosis, understanding the full scope of treatment details is essential for making informed decisions. Liv Hospital’s multidisciplinary team tailors each plan to the patient’s stage, overall health, and personal preferences, ensuring optimal outcomes. In 2022, endometrial cancer accounted for over 65,000 new cases worldwide, highlighting the importance of early detection and precise therapy. This page walks international patients through every aspect of care—from accurate staging and surgical options to radiation, systemic therapies, and long‑term survivorship support. Whether you are planning a consultation from abroad or seeking clarity on the next steps after surgery, the information below provides a clear roadmap.
Our approach integrates cutting‑edge technology, such as robotic‑assisted surgery and advanced imaging, with compassionate patient services that include interpreter support, transportation, and accommodation assistance. By the end of this guide, you will have a comprehensive view of the treatment details that Liv Hospital offers for endometrial cancer, empowering you to collaborate confidently with your medical team.
Accurate staging is the cornerstone of effective treatment planning. The International Federation of Gynecology and Obstetrics (FIGO) system categorizes endometrial cancer from Stage I (confined to the uterus) to Stage IV (spread beyond the pelvis). Precise staging relies on a combination of imaging, pathology, and clinical evaluation.
Understanding these details helps patients anticipate the intensity of subsequent therapies and aligns expectations with the multidisciplinary team’s recommendations.
Surgery remains the primary curative modality for early‑stage disease. The choice of procedure depends on tumor grade, depth of myometrial invasion, and patient comorbidities.
Liv Hospital employs the Da Vinci® robotic platform, offering three major advantages:
These treatment details enable patients to discuss surgical preferences with their oncologic surgeon, balancing oncologic safety with quality‑of‑life considerations.
Radiation is employed as an adjuvant therapy for intermediate‑ to high‑risk disease, or as a primary modality when surgery is contraindicated.
High‑dose rate (HDR) brachytherapy places a small radioactive source directly within the vaginal canal, offering focused treatment with minimal systemic effects.
Decision‑making incorporates tumor stage, surgical margins, and patient tolerance. A typical recommendation matrix might look like :
Liv Hospital’s radiation oncology team utilizes image‑guided planning to maximize tumor control while preserving bowel, bladder, and bone marrow health—critical treatment details for international patients seeking safe travel after therapy.
Combination protocols are standard for high‑risk or metastatic disease. The most common regimen includes:
Response rates approach 50–60 % in stage III–IV disease, with manageable toxicity profiles when supportive care is provided.
For tumors exhibiting microsatellite instability (MSI‑H) or mismatch repair deficiency (dMMR), checkpoint inhibitors such as pembrolizumab have shown durable responses.
Multidisciplinary meetings determine whether hormonal therapy, chemotherapy, or immunotherapy—or a combination—best fits the patient’s disease biology. A simplified decision flow:
These comprehensive treatment details ensure that each patient receives a regimen aligned with the tumor’s molecular profile and personal health goals.
Long‑term monitoring is vital to detect recurrences early and manage treatment‑related side effects.
Common issues after multimodal therapy include:
Liv Hospital provides a 360‑degree survivorship program that includes:
By integrating these follow‑up treatment details into a personalized survivorship plan, patients maintain quality of life while minimizing the risk of disease recurrence.
Liv Hospital is a JCI‑accredited private facility in Istanbul, dedicated to delivering world‑class oncology care to patients from around the globe. Our multidisciplinary teams combine expertise in robotic surgery, advanced radiation, and cutting‑edge systemic therapies, all coordinated through a seamless international patient service that handles appointments, visas, transportation, interpreter support, and comfortable accommodation. Trust in a hospital where clinical excellence meets personalized hospitality.
Ready to discuss your personalized endometrial cancer plan? Contact Liv Hospital today to schedule a virtual consultation and start your journey toward effective, compassionate care.
Send us all your questions or requests, and our expert team will assist you.
Total hysterectomy with bilateral salpingo‑oophorectomy removes the uterus, cervix, ovaries, and fallopian tubes and is the standard curative approach for early‑stage disease. Lymphadenectomy provides staging information and may remove microscopic disease in the pelvic and para‑aortic nodes. Sentinel lymph node mapping uses indocyanine green fluorescence to identify key nodes, reducing morbidity while preserving staging accuracy. For patients who qualify, Liv Hospital also offers robotic‑assisted surgery, which provides enhanced dexterity, less blood loss, and faster recovery. The choice among these techniques depends on tumor grade, depth of myometrial invasion, and the patient’s overall health and preferences.
The International Federation of Gynecology and Obstetrics (FIGO) staging categorizes endometrial cancer from Stage I (confined to the uterus) to Stage IV (distant metastasis). Initial evaluation often starts with transvaginal ultrasound to measure endometrial thickness. Magnetic Resonance Imaging (MRI) provides detailed soft‑tissue contrast to assess myometrial invasion and cervical involvement. PET‑CT is employed when there is suspicion of nodal spread or distant metastasis, guiding both surgical planning and radiation fields. Endometrial biopsy or hysteroscopic curettage confirms histology and tumor grade, completing the staging work‑up.
After surgery, patients with intermediate or high‑risk features (e.g., Stage IB grade 2 or higher) may receive external beam radiation therapy (EBRT) to the pelvis, often combined with vaginal brachytherapy for local control. Low‑risk patients (Stage IA, grade 1) typically do not require radiation. EBRT is delivered in 45–50.4 Gy over 5–6 weeks, with intensity‑modulated techniques (IMRT) minimizing exposure to surrounding organs. Vaginal brachytherapy delivers high‑dose radiation directly to the vaginal cuff, reducing systemic side effects. The decision is individualized based on surgical margins, lymph node status, and patient tolerance.
For low‑grade, estrogen‑receptor positive tumors, progestin‑based hormonal therapy offers a low‑toxicity oral option, often used when surgery is not possible or as maintenance. High‑grade or advanced disease is typically treated with a carboplatin (AUC 5–6) and paclitaxel (175 mg/m²) regimen administered every 21 days for six cycles, achieving response rates of 50‑60 % in stage III‑IV disease. Tumors with microsatellite instability‑high (MSI‑H) or mismatch repair deficiency (dMMR) may benefit from pembrolizumab, a checkpoint inhibitor approved after prior therapy and sometimes used frontline in selected cases. Multidisciplinary tumor boards at Liv Hospital tailor the regimen to each patient’s molecular profile and overall health.
International patients receive a dedicated concierge team that helps with visa applications, airport transfers, and local transportation. Multilingual interpreter services are available for consultations, imaging, and post‑operative care. The hospital offers comfortable, short‑term accommodation close to the medical campus, and nutrition plans that respect cultural dietary preferences. After discharge, patients can continue follow‑up via tele‑medicine, allowing them to stay in touch with their oncology team while returning home. Psychosocial counseling, physiotherapy, and survivorship programs are also customized for patients traveling from abroad.
BlogCancerFeb 19, 2026Patients often ask if they’ll be asleep during polyp removal. It depends on the polyp’s type an...
BlogCancerFeb 18, 2026Gynecological malignancies are cancers that affect the female reproductive system. They need accurate ICD-1...
BlogCancerFeb 18, 2026Diagnosis code C57.9 is a key ICD-10 code. It classifies malignant neoplasms of unspecified female genital ...
BlogCancerNov 03, 2025The Canadian Cancer Society says most women with uterine cancer get surgery. The surgery type depends on th...
BlogCancerNov 03, 2025Having a total hysterectomy is a big decision that affects a woman’s health. One worry is the chance ...
BlogCancerNov 03, 2025Many women feel anxious about medical imaging procedures. A transvaginal ultrasound is a tool used to see i...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
